share_log

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

以下是15年前投資於生物遺傳公司的100美元今天的價值
Benzinga Real-time News ·  2022/06/28 00:15

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.63% on an annualized basis producing an average annual return of 10.11%. Currently, Biogen has a market capitalization of $31.20 billion.

生物遺傳研究(納斯達克:BIIB)過去15年的年化表現優於大市3.63%,平均年回報率為10.11%。目前,Biogen的市值為312.億美元。

Buying $100 In BIIB: If an investor had bought $100 of BIIB stock 15 years ago, it would be worth $430.05 today based on a price of $213.03 for BIIB at the time of writing.

在BIIB購買100美元:如果一位投資者在15年前購買了100美元的BIIB股票,那麼這筆錢就值了$430.05今天,以撰寫本文時BIIB的213.03美元價格計算。

Biogen's Performance Over Last 15 Years

生物遺傳研究公司過去15年的業績

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

最後--這一切有什麼意義?從這篇文章中獲得的關鍵見解是注意到複合回報在一段時間內可以在你的現金增長中產生多大的差異。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閲。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論